Tvardi Therapeutics (TVRD) Tax Rate (2013 - 2020)

Tvardi Therapeutics (TVRD) posted Tax Rate of 0.32% for Q4 2020, down 140.87% sequentially from 0.79% in Q3 2020.

Tvardi Therapeutics (TVRD) Tax Rate (2013 - 2020) Analysis & Trends

Tvardi Therapeutics has reported Tax Rate for 8 years, with the latest figure at 0.32% in Q4 2020.

Quarterly Tax Rate changed N/A year-over-year to 0.32% in Q4 2020, while the trailing twelve-month figure through Sep 2021 was 1.08% (down 181.0% YoY) and the FY2024 annual result came in at 0.56%, changed N/A from the prior year.
Tax Rate retreated to 0.32% in Q4 2020 per TVRD's latest filing, from 0.79% in the prior quarter.
Over five years, Tax Rate peaked at 1.34% in Q1 2016 and troughed at 0.32% in Q4 2020.
A 5-year average of 0.55% and a median of 0.6% in 2016 frame the typical range for Tax Rate.
The widest YoY moves for Tax Rate: up 102 bps in 2016, down 354 bps in 2016.
Over 5 years, Tax Rate stood at 0.85% in 2016, then tumbled by 79 bps to 0.18% in 2017, then jumped by 229 bps to 0.6% in 2018, then jumped by 38 bps to 0.83% in 2019, then slumped by 139 bps to 0.32% in 2020.
According to Business Quant data, Tax Rate over the past three periods registered 0.32%, 0.79%, and 0.72% for Q4 2020, Q3 2020, and Q2 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	138.57 Bn	130.72 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	85.98 Bn	77.99 Bn	3.93 Bn	15.11%
3	Argenx Se	65.11 Bn	59.92 Bn	1.37 Bn	10.91%
4	Moderna	55.73 Bn	50.59 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.99 Bn	36.89 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	31.64 Bn	28.33 Bn	992.69 Mn	7.49%
7	BioNTech SE	27.70 Bn	9.31 Bn	668.28 Mn	34.12%
8	Insmed	27.46 Bn	26.30 Bn	358.27 Mn	-16.71%
9	Royalty Pharma	27.32 Bn	26.49 Bn	-	-
10	Tvardi Therapeutics	17.73 Mn	17.73 Mn	-	-

Download Data